Ex Parte Elton et alDownload PDFPatent Trial and Appeal BoardMar 12, 201814123596 (P.T.A.B. Mar. 12, 2018) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/123,596 12/03/2013 Richard K. Elton 289-PDD-11-041 US 5498 79990 7590 C. R. Bard, Inc. Bard Peripheral Vascular, Inc. 1415 W. 3rd Street P.O. Box 1740 Tempe, AZ 85280-1740 EXAMINER MANNAN, MIKAIL A ART UNIT PAPER NUMBER 3731 NOTIFICATION DATE DELIVERY MODE 03/14/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): BPVIP.Docket@crbard.com Charles .Runyan @ crbard. com raust@ austiplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RICHARD K. ELTON and COREY E. STAPLETON Appeal 2017-001863 Application 14/123,596 Technology Center 3700 Before JEFFREY N. FREDMAN, JOHN E. SCHNEIDER, and DAVID COTTA, Administrative Patent Judges. FREDMAN, Administrative Patent Judge. DECISION ON APPEAL This is an appeal1 under 35 U.S.C. § 134 involving claims to a non- compliant medical balloon for performing an angioplasty. The Examiner rejected the claims as anticipated and as obvious. We have jurisdiction under 35 U.S.C. § 6(b). We affirm-in-part. Statement of the Case Background “Balloon angioplasty is routinely used to remove blockages in the tubular organs such as arteries or veins. . . . Besides high pressure requirements, the angioplasty balloons also must be resistant to puncture and scratch, easy to track and push, and present a low profile” (Spec. 1). 1 Appellants identify the Real Party in Interest as C.R. Bard, Inc. (see App. Br. 2). Appeal 2017-001863 Application 14/123,596 “Because of its relatively high viscosity, there is also a need to eliminate or reduce the use of contrast agent used in inflation/deflation of the balloons” (Spec. 1). “Furthermore, the physician performing the angioplasty procedure should be able to locate the position of the uninflated balloon with accuracy, so that the balloon will be properly positioned during and after inflation” (Spec. 2). The Claims Claims 1, 2, 5-21, 27-29, 31, and 53 are on appeal. Claims 1 and 27 are representative and read as follows: 1. A non-compliant medical balloon for performing an angioplasty, comprising: a body including a non-compliant wall having an inner layer, an outer layer, and a discrete, intermediate layer at least partially between the inner and outer layer, at least the intermediate layer comprising a film including a radiopaque material. 27. A medical balloon for performing an angioplasty, comprising: a barrel portion including a first radiopaque foil or film; and a first cone portion including a second radiopaque foil or film. The Issues A. The Examiner rejected claims 1, 2, 5-12, 27, 31, and 53 under 35 U.S.C. § 102(b) as anticipated by Tilson2 (Final Act. 5-6). 2 Tilson et al., US 2009/0299327 Al, published Dec. 3, 2009. 2 Appeal 2017-001863 Application 14/123,596 B. The Examiner rejected claims 13-15 under 35 U.S.C. § 103(a) as obvious over Tilson and Allex3 (Final Act. 6-7). C. The Examiner rejected claims 20 and 21 under 35 U.S.C. § 103(a) as obvious over Tilson, Allex, and Pepin4 (Final Act. 7). D. The Examiner rejected claims 28 and 29 under 35 U.S.C. § 103(a) as obvious over Tilson and Pepin (Final Act. 8). E. The Examiner rejected claims 16-19 under 35 U.S.C. § 103(a) as obvious over Tilson, Allex, and Bartholf5 (Final Act. 8-10). A. 35 U.S.C. § 102(b) over Tilson The Examiner finds Tilson discloses a non-compliant medical balloon (20) for performing an angioplasty, comprising: a body (surface of balloon) including a non-compliant wall (balloon can be noncompliant, Paragraph [0092]; balloon wall 22) having an inner layer (inner layer 72b), an outer layer (outer layer 72a), and a discrete, intermediate layer (middle layer 72c) at least partially between the inner and outer layer, at least the intermediate layer comprising a film including a radiopaque material (middle layer may comprise several layers, at least one may have a radiopaque material, Paragraph [0061]—[0063]; the film may be a polymer with radiopaque particulates, Para [0061], [0370]—[0374]). (Final Act. 5). Appellants contend claim 1 requires “the intermediate layer comprising a film including a radiopaque material” and that as “noted 3 Allex et al., US 2010/0234875 Al, published Sept. 16, 2010. 4 Pepin et al., US 5,531,721, issued July 2, 1996. 5 Bartholf et al., US 6,942,688 B2, issued Sept. 13, 2005. 3 Appeal 2017-001863 Application 14/123,596 in Appellant’s specification, such a film ‘refer[s] to preformed films of polymeric materials incorporating a radiopaque material or blend of materials.’ Specification, para. [0037]” {App.Br. 6). Appellants contend the “rejection does not explain how the claimed film is disclosed in the Tilson reference, but simply contends a ‘radiopaque film’ is ‘a layer having a radiopaque material’” {id. at 7). Appellants contend that “[mjerely because Tilson has layers does not establish that one of these layers is a film including a radiopaque material - the middle layer could be fibers, unbound particulate materials, or any number of things” {id. at 7). The issue with respect to this rejection is: Does the evidence of record support the Examiner’s conclusion that Tilson anticipates claims 1, 27, and 31? Findings of Fact 1. The Specification teaches radiopacity may be provided to the balloon 10 by the presence of a radiopaque film 35 or foil 36 as an intermediate layer 34 of the balloon wall 28. Radiopaque foils refer to metal foils produced from metals which exhibit a sufficiently high absorption of X-rays . . . Examples of such metal foils include, but are not limited to, thin foils made from, platinum, gold, silver, tin, copper, iridium, palladium, lead, and many other similar metals. (Spec. 7). 2. The Specification teaches: “Radiopaque films refer to preformed films of polymeric materials incorporating a radiopaque material or blend of materials” (Spec. 8). 4 Appeal 2017-001863 Application 14/123,596 3. The Specification teaches: Examples of film polymers include thermoplastic and thermoset polymers. Some examples of thermoplastic polymers include, but are not limited to, polyurethanes, polyamides, polyether- polyamide copolymers such as PEBAX, polyethylene terephthalate or other polyesters, polyvinyl acetate, polyvinyl chloride, and many other thermoplastic materials useful for making films. Some examples of thermoset polymers include, but are not limited to, crosslinked polyurethanes, polyureas, epoxies, acrylics, silicones, and many other thermoset materials that can be formed into thin films. (Spec. 8). 4. The Specification teaches “providing the balloon with a radiopacity substantially from a first end to a second end, the radiopacity provided at least in part by a foil or film” (Spec. 4). 5. The Specification teaches “the film 35 may be provided on both the intermediate section 16 and the end sections 18, 20, or one or both of these sections may instead be covered by a foil 36” (Spec. 6). 6. Tilson teaches: The panel or radiopaque foil pattern can have panel arms that can be folded over a balloon 20 during manufacture such that radiopaque foil panel can be embedded within the balloon wall 22. The radiopaque foil and any other radiopaque or metal element herein can be made from gold, platinum, platinum- iridium alloy, tantalum, palladium, bismuth, barium, tungsten, or combinations thereof. Any of the layers can have particles of gold, platinum, platinum-iridium alloy, tantalum, palladium, bismuth, barium, tungsten or combinations thereof. Any of the layers can have radiopaque dyes. (Tilson T| 356). 5 Appeal 2017-001863 Application 14/123,596 7. Figure 460 of Tilson is reproduced below: BB-S8 Figure 460 (labeled 46P in the Tilson text) illustrates that the outer layer 12a can be an MMA-resistant and MMA-releasing polymer film. The inner layer 12b can be a leak proof bladder made from a polymer film. The first middle layer 12c can be a fiber tape, for example with the fibers oriented as longitudinal fibers. The second middle layer 12d can be a resin or adhesive. The third middle layer 12e can be a fiber tape, for example with the fibers oriented as latitudinal or hoop fibers. The fourth middle layer 72/can be a resin or adhesive. The fifth middle layer 72s can be a radiopaque layer, such as a metal foil. The sixth middle layer 12h can be a resin or adhesive. (Tilson 384; emphasis added). 8. Tilson teaches: The first middle layer can have a radiopaque material and be substantially contiguous throughout the wall. For example, the first middle layer can have a metal foil. The first middle layer can have a radiopaque material in non-powder form. The first middle layer can have less than about 100 pieces of radiopaque material. The radiopaque material can covers (not necessarily on the top surface) at least about 30% of the area of the wall of the balloon. The first middle layer can have a first elongated 6 Appeal 2017-001863 Application 14/123,596 member that can have a radiopaque material. For example, the elongate member can be a strip, such as the strip described herein. (Tilson lj 61). 9. Tilson teaches the “first middle layer can have a fiber. The second middle layer can have a radiopaque material. The first middle layer can be between the inner layer and the second middle layer” (Tilson 62). 10. Tilson teaches “balloon 20 . . . can be used for Kyphoplasty, angioplasty” (Tilson 531). 11. Tilson teaches a “polymer film may be coated with a material. The coating may be applied by, for instance, sputter coating. The material that is coated on the polymer film may provide substantial radiopacity” (Tilson If 451). Principles of Law “The protocol of giving claims their broadest reasonable interpretation during examination does not include giving claims a legally incorrect interpretation. This protocol is solely an examination expedient, not a rule of claim construction.” In re Skvorecz, 580 F.3d 1262, 1267 (Fed. Cir. 2009). Anticipation under 35 U.S.C. § 102 requires that “‘each and every element as set forth in the claim is found, either expressly or inherently described, in a single prior art reference.”’ In re Robertson, 169 F.3d 743, 745 (Fed. Cir. 1999). 7 Appeal 2017-001863 Application 14/123,596 Analysis Claim 1 We begin with claim interpretation because before a claim is properly interpreted, its scope cannot be compared to the prior art. For claim 1, the dispute centers over the phrase “a film including a radiopaque material.” We first turn to the Specification to interpret this phrase. The Specification states: “Radiopaque films refer to preformed films of polymeric materials incorporating a radiopaque material or blend of materials” (FF 2). The Specification explains that examples of such film polymers “include thermoplastic and thermoset polymers” (FF 3). The Specification contrasts such films with radiopaque foils made from thin foils of metals (FF 1). We agree with Appellants that the claim phrase “a film including a radiopaque material” is reasonably interpreted in light of the Specification as limited to polymeric films with a radiopaque material incorporated into the polymer itself, not layered, coated, or sputtered onto a polymer. We are not persuaded by the Examiner’s contention that “any of the layers may further comprise a film, and that film may be interpreted as the intermediate layer film as in Paragraph [0449]” (Ans. 3). This interpretation is inconsistent with the express definition of film in the Specification as requiring polymeric materials. The correct inquiry in giving a claim term its broadest reasonable interpretation in light of the specification is not whether the specification proscribes or precludes some broad reading of the claim term adopted by the examiner. And it is not simply an interpretation that is not inconsistent with the specification. It is an interpretation that corresponds with what 8 Appeal 2017-001863 Application 14/123,596 and how the inventor describes his invention in the specification, i.e., an interpretation that is “consistent with the specification.” In re Morris, 127 F.3d 1048, 1054 (Fed. Cir. 1997). In re Smith International, Inc., 871 F.3d 1375, 1382-83 (Fed. Cir. 2017). Turning to the anticipation rejection, Tilson teaches radiopaque foils (FF 6) that may be placed in intermediate layers in angioplasty balloons (FF 8). The Examiner does not identify, and we do not find, any teaching in Tilson suggesting a polymeric film that incorporates radiopaque materials consistent with our interpretation of claim 1 in light of the Specification {see, e.g., Ans. 3). While the Examiner contends that the term “a polymer film” is not a limitation of claim 1, we disagree, and conclude that the phrase “a film including a radiopaque material” is limited to polymeric films with a radiopaque material incorporated into the polymer itself as discussed above. Therefore, we agree with Appellants that Tilson does not anticipate claim 1. Claim 27 We again begin with claim interpretation and for claim 27, the dispute centers over the phrases “a first radiopaque foil or film; and ... a second radiopaque foil or film.” We turn to the Specification to interpret whether barrel and cone portions of the balloon have the same or different foil materials. The Specification teaches “the film 35 may be provided on both the intermediate section 16 and the end sections 18, 20, or one or both of these sections may instead be covered by a foil 36” (FF 5). Thus, while the Specification does contemplate foils with different radiopacities, the Specification also contemplates the situation where radiopaque components cover both the 9 Appeal 2017-001863 Application 14/123,596 intermediate and end sections, resulting in a first and second regions with the same radiopacity (FF 5). Claim 27 does not require that the first and second radiopaque foils differ in their radiopacity or in any other way. We therefore agree with the Examiner that, consistent with the Specification and claim language, the first and second radiopaque foils in claim 27 may have the same radiopacity. Cf. Linear Technology Corp. v. International Trade Commission, 566 F.3d 1049, 1055 (Fed.Cir. 2009) (“We agree with the Commission’s construction of ‘second circuit’ and ‘third circuit,’ defining the terms broadly to not require entirely separate and distinct circuits. Indeed, there is nothing in the claim language or specification that supports narrowly construing the terms to require a specific structural requirement or entirely distinct ‘second’ and ‘third’ circuits.”) Tilson teaches a medical balloon for performing angioplasty (FF 10) that may comprise a radiopaque foil (FF 6-7) composed of multiple portions such as strips (FF 8). We are not persuaded by Appellants’ contention that “[e]ven if correct, this does not establish the presence of different foils or films on the cone and barrel portions of Tilson, as the instant claim requires” (App. Br. 8), because claim 27 does not include any requirement that the first and second foil portions differ in any way, nor does the Specification impose such a requirement (see Claim 27, FF 5). 10 Appeal 2017-001863 Application 14/123,596 Claim 31 We begin with claim interpretation. Claim 31 requires: “A balloon for performing an angioplasty comprising a body having a radiopaque decal comprising a polymer film applied thereto.” The Specification teaches “outer layer 32 may also comprise a radiopaque film, such as for example a radiopaque applique or decal 44 attached to the balloon 10, which may otherwise be formed of non-radiopaque materials” (Spec. 10). We interpret the decal as requiring at least a polymeric film and a radiopaque element that is attached to that film. Claim 31 does not clearly require the decal to be composed of a polymer film that incorporates a radiopaque material nor does the Specification expressly require the decal to be formed with a polymer film incorporating a radiopaque material. Tilson teaches an embodiment where a “polymer film may be coated with a material. The coating may be applied by, for instance, sputter coating. The material that is coated on the polymer film may provide substantial radiopacity” (FF 11). Appellants contend the Examiner “does not establish that Tilson describes a radiopaque decal comprising a polymer film. The rejection does not even address the word ‘decaf in the claim, which is simply ignored” (App. Br. 8). We find this argument unpersuasive because “the reference need not satisfy an ipsissimis verbis test.” In re Cleave, 560 F.3d 1331, 1334 (Fed. Cir. 2009). There is no requirement that Tilson use the term “decal” to anticipate the claimed structure. Tilson must simply teach a structure that falls within the scope of the claim as reasonably interpreted. “[Ajpparatus 11 Appeal 2017-001863 Application 14/123,596 claims cover what a device is, not what a device does.'1'’ Hewlett-Packard Co. v. Bausch & Lomb Inc., 909 F.2d 1464, 1468 (Fed. Cir. 1990). Here, the apparatus of claim 31 is a balloon with a polymer film that has some type of radiopaque material applied thereto. Tilson teaches a balloon with a polymer film that may have a radiopaque material sputtered onto the polymer film (FF 11). Unlike claim 1, which reasonably requires the film to incorporate the radiopaque material, claim 31 expressly encompasses a radiopaque material that is applied to a polymer film as in the sputtering process of Tilson (FF 11). Conclusion of Law The evidence of record does not support the Examiner’s conclusion that Tilson anticipates claim 1. The evidence of record supports the Examiner’s conclusion that Tilson anticipates claims 27 and 31. Claim 53 falls with claim 31. B., C., E. 35 U.S.C. § 103(a) over claims dependent on claim 1 The Examiner relies upon Tilson for each of these rejections to teach a “film including a radiopaque material” (see Final Act. 6-10). Having reversed the anticipation rejection of claim 1 over Tilson because Tilson does not teach a “film including a radiopaque material” for the reasons given above, we also find that the further combinations with Allex, Pepin, and Bartholf do not render the rejected claims obvious for the same reason. 12 Appeal 2017-001863 Application 14/123,596 D. 35 U.S.C. § 103(a) over claims dependent on claim 27 Appellants contend: “Regarding claim 28, it requires: (1) a first cone portion including a second radiopaque foil or film; and (2) a second cone portion having a third radiopaque foil or film. The rejection does not contend that Tilson or Pepin disclose the claimed two cone portions of a balloon with the foils or films” (App. Br. 12). Appellants also contend the “further requirement of claim 29 that the RO materials applied to the cones is the same has also not been shown to be present in the references” {id.). The Examiner contends the third radiopaque material may be the same as the first and the second radiopaque material, which is applied to the entirety of the balloon as in Paragraph [0346] of Tilson. Further, multiple layers can have a radiopaque foil or film and each can be on the entire of the balloon; where the layers would encompass the cone portions as in Paragraphs [0356] and [0053], see Fig. 5A. (Ans. 7). Appellants respond paragraph 356 of Tilson fails to describe that “multiple layers can have a radiopaque foil or film and each can be on the entire of the balloon,” as alleged. The same is true for paragraph 53, which as noted above does not afford a factual predicate for the Examiner’s contentions. Neither does Figure 5A, which does not disclose any “cone portion” at all. (Reply Br. 8). We find the Examiner has the better position. Tilson teaches a “single radiopaque layer can encompass substantially the entire area of the balloon” (Tilson 346), reasonably supporting the Examiner’s position that every portion of the balloon may be coated with radiopaque material. Figure 29A 13 Appeal 2017-001863 Application 14/123,596 reasonably depicts two tapers from a broader to narrower element comprising a “cone” shape near element 56a and 56b (see Fig. 29A), reasonably satisfying the requirement for a first and second cone portion even if they must be different. Appellants provide no evidence to the contrary. Therefore, Tilson teaches a balloon satisfying the requirement of claims 28 and 29. SUMMARY In summary, we reverse the rejection of claims 1, 2, and 5-12 under 35 U.S.C. § 102(b) as anticipated by Tilson. We affirm the rejection of claims 27, 31, and 53 under 35 U.S.C. § 102(b) as anticipated by Tilson. We reverse the rejection of claims 13-15 under 35 U.S.C. § 103(a) as obvious over Tilson and Allex. We reverse the rejection of claims 20 and 21 under 35 U.S.C. § 103(a) as obvious over Tilson, Allex, and Pepin. We affirm the rejection of claims 28 and 29 under 35 U.S.C. § 103(a) as obvious over Tilson and Pepin. We reverse the rejection of claims 16-19 under 35 U.S.C. § 103(a) as obvious over Tilson, Allex, and Bartholf. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFlRMED-fN-PART 14 Copy with citationCopy as parenthetical citation